Skip to content

The Comparison about Sensitivity of Upper and Lower Limb Perfusion Indexes PI to Predict Hypotension after Cesarean Section Spinal Anesthesia

The Comparison about Sensitivity of Upper and Lower Limb Perfusion Indexes PI to Predict Hypotension after Cesarean Section Spinal Anesthesia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014328
Enrollment
Unknown
Registered
2018-01-06
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section hypotension

Interventions

Gold Standard:Noninvasive blood pressure monitoring
Index test:Masimo&#32
Machine&#32

Sponsors

Zhengdong Hospital, First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 40 years old, gestational age 36 to 41 weeks; 2. Patients scheduled for cesarean section undergoing spinal anesthesia for 1-3 hours of operation; 3. ASA classification I ~ III level; 4. BMI 18.5-39.9 kg / m2 [BMI = body weight (Kg) / height (m) 2] (2013 American Guidelines for Management of Overweight and Obese Adults); 5. In line with ethics, patients volunteered, signed informed consent.

Exclusion criteria

Exclusion criteria: 1. cesarean section with placenta previa, placental abruption, pre-Zhao Xian Xian, etc.; 2. Patients with complications (cardiovascular and cerebrovascular diseases, diabetes, peripheral neuropathy, anxiety, etc.); 3. obese patients with BMI=40kg/m2; 4. preoperative blood pressure = 180/110 mm Hg (WHO-ISH Hypertension Guide Grade 3 hypertension); 5. identify / suspect abuse or long-term use of narcotic sedation analgesics; 6. contraindications to narcotic drugs or contraindications to allergies and spinal anesthesia; 7. within six months of taking hormone> 10 days or have a history of adrenal cortex suppression or have immune system diseases; 8. Patients who participated in other studies within 30 days.

Design outcomes

Primary

MeasureTime frame
PI;

Contacts

Public ContactZhisong Li

First Affiliated Hospital of Zhengzhou University

lzszd@126.com+86 13783573974

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026